FDA Blind Spots Spark Rise in Drug and Device Recalls

C

FDA leaders have overlooked key issues, leading to more recalls of medicines and medical devices. Americans can no longer be sure their prescriptions meet strict safety rules. This oversight problem has grown worse over the years.

Americans expect that every prescription they get from the pharmacy has been checked by FDA experts for quality and safety. But recent events show this trust is not always deserved. The agency seems to miss important problems in how drugs and devices are made.

For many years, the FDA relied on in-person checks at factories to ensure good manufacturing practices. This system worked when there were enough staff and resources. Now, with changes in leadership and focus, those checks have become less effective.

As a result, recalls of medical products have surged. Faulty devices and contaminated drugs reach the market more often. This puts patients at risk and raises questions about the FDA's ability to protect public health.

Original Author: David Gortler, Pharm. D | Source: Brownstone Institute

83.428 SRY
LIBERTY
Write your comment...

Comments